Six more countries add Prevenar to their immunisation programmes
This article was originally published in Scrip
Executive Summary
Wyethhas praised six countries for including its seven-valent pneumococcal conjugate vaccine, Prevenar, in their immunisation programmes. Cyprus, Bahrain, Hungary, Ireland, Slovakia and Sweden have become the latest countries to announce that they will routinely immunise infants against pneumococcal disease using Prevenar. This brings the total number of countries to include the vaccine in their programmes to 24, according to Wyeth. The company also points to Germany for proof of the vaccine's worth. "Since the introduction of PCV7 into Germany's paediatric immunisation schedule in 2006, there has been a 50% reduction in vaccine-type invasive pneumococcal disease in children younger than two years old compared with a pre-vaccine base-line", the company says. Pneumococcal disease leads to 1.6 million deaths a year across the world.
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.